The earnings call presented a mix of positive developments and challenges. While the company reported strong diagnostics revenue growth and successful integration of Sherlock Biosciences, it faced significant headwinds from funding uncertainties and disruptions in the Sample Management Solutions segment. The overall sentiment is balanced with positive steps towards innovation and growth, countered by challenges in funding and customer disruptions.

Company Guidance -

Q3 2025

During the OraSure Technologies 2025 First Quarter Earnings Call, the company provided guidance for the second quarter, projecting total revenue of $28.5 million to $32.5 million and core revenue of $28 million to $32 million, excluding COVID-19 and risk assessment testing revenues, which are expected to contribute approximately $5 million. The company anticipates its gross margin percentage to be flat or slightly up compared to the first quarter, with potential expansion in the second half of the year driven by increased volumes and efficiencies from automation and site consolidation. Operating expenses in Q2 are expected to include core expenses in the low $20 million range, plus $10 million in innovation investments, of which $7 million to $8 million are related to the Sherlock acquisition. The company also announced a $40 million stock repurchase program over the next two years, funded from cash on hand, aligning with their capital deployment strategy.

Core Revenue Performance

Q1 core revenue was $29.5 million, above the midpoint of the guidance range, and flat year-over-year after adjusting for the exit from the risk assessment testing business.

Diagnostics Revenue Growth

Diagnostics revenue grew 8% year-over-year, driven by international business and initial orders for WHO PQ listed hepatitis C self-test.

Successful Integration of Sherlock Biosciences

Integration of Sherlock Biosciences is progressing well, contributing to OTI's product pipeline with molecular diagnostics innovation.

Stock Repurchase Program

Board authorized the repurchase of up to $40 million of common stock over the next two years, funded from cash on hand.

International Business Stability

International Diagnostics business remains steady despite funding uncertainties, with growth driven by hepatitis C self-test orders.

New Product Launches

Planned product launches include microbiome extraction kits, blood proteomics sample stabilization, and entrance into the small volume self-collected blood segment.

Orasure Technologies (OSUR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

OSUR Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	-0.18 / -	-0.06	―	―	―
Aug 05, 2025	2025 (Q2)	-0.20 / -0.26	-0.01	-2500.00% (-0.25)	―
May 07, 2025	2025 (Q1)	-0.16 / -0.21	-0.05	-320.00% (-0.16)	―
Feb 25, 2025	2024 (Q4)	-0.06 / -0.14	0.27	-151.85% (-0.41)	―
Nov 06, 2024	2024 (Q3)	-0.08 / -0.06	0.15	-140.00% (-0.21)	―
Aug 06, 2024	2024 (Q2)	>-0.01 / -0.01	-0.07	85.71% (+0.06)	―
May 08, 2024	2024 (Q1)	- / -0.05	0.37	-113.51% (-0.42)	―
Feb 27, 2024	2023 (Q4)	0.09 / 0.27	0.21	28.57% (+0.06)	―
Nov 07, 2023	2023 (Q3)	0.05 / 0.15	0.07	114.29% (+0.08)	―
Aug 03, 2023	2023 (Q2)	-0.07 / -0.07	-0.26	73.08% (+0.19)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

OSUR Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$3.12	―	―
May 07, 2025	$2.79	$2.60	-6.81%
Feb 25, 2025	$4.00	$3.06	-23.50%
Nov 06, 2024	$4.40	$4.24	-3.64%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Orasure (OSUR) report earnings?

Orasure (OSUR) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Orasure (OSUR) earnings time?

Orasure (OSUR) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is OSUR EPS forecast?

OSUR EPS forecast for the fiscal quarter 2025 (Q3) is -0.19.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing